February 2023 – Israel Biotech Fund

AION Labs Launches AI Startup for De Novo Antibody Design

February 28th, 2023 by Sarit Steinberg

Novel Alliance Responds to Big Pharma’s Most Pressing AI/ML Needs

February 8th, 2023 by Sarit Steinberg

At AION Labs, Pfizer, AstraZeneca, Merck KgGA and Teva Pharmaceuticals have partnered with the Israel Innovation Authority, Israeli Biotech Fund, Amazon Web Services and Germany’s BioMed X Institute to create and adopt gateway AI and computational technologies for drug discovery and development.

MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market

February 4th, 2023 by Sarit Steinberg

MediWound announced that it has entered into a definitive securities purchase agreement for the sale and purchase of1,964,286 shares of the Company’s ordinary shares, par value NIS 0.07, at a purchase price of $14 per share, in a registered direct offering.